Literature DB >> 28442257

Cocaine use is associated with a higher prevalence of elevated ST2 concentrations.

Xander M R van Wijk1, Eric Vittinghoff2, Alan H B Wu3, Kara L Lynch3, Elise D Riley4.   

Abstract

BACKGROUND: Cocaine is a well-known risk factor for acute cardiac events, but the effects in users outside of acute events are less clear. We investigated a possible association between cocaine use and the concentration of a novel biomarker for cardiac stress and heart failure, ST2.
METHODS: A case-control study was conducted to compare ST2 concentrations by the presence of cocaine in patients presenting for care, but not cardiac care, at an urban safety net hospital.
RESULTS: In samples taken from 100 cocaine-positive and 100 cocaine-negative patients, the presence of cocaine was associated with ST2 concentrations>35ng/mL. Serum concentrations of benzoylecgonine, a major cocaine metabolite, were significantly correlated with ST2 concentrations.
CONCLUSIONS: Cocaine use is associated with subclinical cardiac stress and damage outside of acute cardiac events. This information could add to better stratification of cocaine users with elevated ST2 concentrations who may be at higher risk for developing heart failure and other cardiac complications.
Copyright © 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Benzoylecgonine; Cardiac stress; Cocaine; Drugs of abuse; ST2

Mesh:

Substances:

Year:  2017        PMID: 28442257      PMCID: PMC5638657          DOI: 10.1016/j.clinbiochem.2017.04.015

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  16 in total

1.  Establishment of reference intervals for soluble ST2 from a United States population.

Authors:  Jun Lu; James V Snider; David G Grenache
Journal:  Clin Chim Acta       Date:  2010-07-21       Impact factor: 3.786

Review 2.  ST2: a novel biomarker for heart failure.

Authors:  Anju Bhardwaj; James L Januzzi
Journal:  Expert Rev Mol Diagn       Date:  2010-05       Impact factor: 5.225

Review 3.  Cocaine: history, social implications, and toxicity--a review.

Authors:  Rachel A Goldstein; Carol DesLauriers; Anthony M Burda
Journal:  Dis Mon       Date:  2009-01       Impact factor: 3.800

Review 4.  ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel.

Authors:  James L Januzzi; Alexandre Mebazaa; Salvatore Di Somma
Journal:  Am J Cardiol       Date:  2015-01-23       Impact factor: 2.778

Review 5.  Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome.

Authors:  Kai M Eggers; Bertil Lindahl
Journal:  Clin Chem       Date:  2016-10-10       Impact factor: 8.327

6.  Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry.

Authors:  Kara L Lynch; Stephen S Dominy; Jonathan Graf; Alexander H Kral
Journal:  J Anal Toxicol       Date:  2011-04       Impact factor: 3.367

7.  Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.

Authors:  Thomas J Wang; Kai C Wollert; Martin G Larson; Erin Coglianese; Elizabeth L McCabe; Susan Cheng; Jennifer E Ho; Michael G Fradley; Anahita Ghorbani; Vanessa Xanthakis; Tibor Kempf; Emelia J Benjamin; Daniel Levy; Ramachandran S Vasan; James L Januzzi
Journal:  Circulation       Date:  2012-08-20       Impact factor: 29.690

8.  Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure.

Authors:  Shafiq U Rehman; Thomas Mueller; James L Januzzi
Journal:  J Am Coll Cardiol       Date:  2008-10-28       Impact factor: 24.094

9.  Higher prevalence of detectable troponin I among cocaine-users without known cardiovascular disease.

Authors:  Elise D Riley; Priscilla Y Hsue; Eric Vittinghoff; Alan H B Wu; Phillip O Coffin; Peter K Moore; Kara L Lynch
Journal:  Drug Alcohol Depend       Date:  2017-01-19       Impact factor: 4.492

10.  Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.

Authors:  Michelle L O'Donoghue; David A Morrow; Christopher P Cannon; Petr Jarolim; Nihar R Desai; Matthew W Sherwood; Sabina A Murphy; Robert E Gerszten; Marc S Sabatine
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.